// App-Quantinova.ai

: Effect of prior year pulmonary exacerbation (PE) frequency on response to ARD-3150 in patients with non-cystic fibrosis bronchiectasis (NCFB) chronically infected with Pseudomonas aeruginosa (PA)

Researchers

Presenter

  • James D. Chalmers

Principal Investigators

  • Bruce Thompson

  • Juergen Froehlich

  • Angela Davis

  • Janice Dahms

  • David Cipolla

  • Igor Gonda

Medical Centers

  • University of Dundee, Dundee, United Kingdom

  • Theta Hat Statistical Consultants LLC, Owings Mills, MD, United States.

  • Aradigm Corp, Hayward, CA, United States,

  • NIH/NIEHS, Research Triangle Park, United States of America

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Cystic Fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • ARD-3150

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved